|
Subscribe / Renew |
|
|
Contact Us |
|
| ► Subscribe to our Free Weekly Newsletter | |
Construction Bids
| home | Welcome, sign in or click here to subscribe. | login |
| FEATURED NOTICE | |
| City of Mukilteo 55th PL W LID Construction | |
| New Bid Calls | 7 |
| New Consultant Notices | 8 |
| New Supply Bids | 0 |
| LAKE STEVENS SECURITY AND PROGRAMMING IMPROVEMENTS PACKAGE 1 – GYMNASIUM Bayley Construction |
| RIDGEFIELD COMMUNITY AND RECREATION CENTER PROJECT TAPANI INC |
| RENTON HIGH SCHOOL REPLACEMENT PHASE 1: MACC 01 - MAIN CONSTRUCTION BID GROUP 1: BP 02A, BP 21A, BP 31A, BP 31D, BP 32B, BP 32C Skanska USA Building Inc. |
| EASTSIDE TREATMENT PLANT UV REPLACEMENT, PROJECT NUMBER 5882 Rognlin's Inc. |
| MT BAKER TOD PHASE 1 - SEATTLE, WA Walsh Construction Co./ WA |
| more » |
| |
August 19, 2020
Bothell-based Seattle Genetics appointed Dr. Ted W. Love to its board. Love is president and CEO of Global Blood Therapeutics, and has over 25 years of experience in the health care and biotechnology/pharmaceutical industries. Concurrent with Love's appointment, Dr. Srinivas Akkaraju resigned from the board after serving 17 years on it.
MyDJC | Business | Construction | Real Estate | Architecture & Engineering | Environment | Machinery | Technology | Weekend
Copyright 2026 Seattle Daily Journal of Commerce | Terms of Service | Privacy Policy | Contact Us | Advertising | Site Index